Data Monitor

CLUSTER DATA

A large collection of Emerging Market Data – indicators and indices:

Click on a region, scroll down or  go2EMMA press

 

SECTOR DATA

A selection of return, risk, impact & fun ‘methodology’:

Click on a section, scroll down or return to Content

 

FRONTIERS TECH STORY

  • Intravenously administered iron oxide nanoparticles with different coatings reversibly perturb immune cells in peripheral blood without inducing toxicity in mice

    IntroductionIron oxide nanoparticle formulations are widely used in clinical applications and have recently been explored for hyperthermia therapy, cancer imaging and treatment. Here, we report the effects of intravenously injected pegylated or poly acrylic acid decorated iron oxide nanoparticles coated with hydroxyethyl starch (HES) on host immune system and organs. These particles were compared with sucrose coated iron oxide nanoparticle (Venofer®) and the coating compound HES–both FDA approved agents–alongside non-iron oxide polystyrene nanoparticles coated with HES (micromer®).MethodsToxicity analysis was performed in healthy female normal FVB/NJ mice 60 days after nanoparticle injection, with complete blood analysis conducted at multiple time-points. In a separate cohort, nanoparticle biodistribution 24 h post-intravenous injection was evaluated using a HER2 overexpressing breast cancer mouse model.ResultsToxicity analysis revealed no adverse effects on liver or kidneys with any of the tested formulations after 60 days. Immune cell perturbations were observed at early time points following iron oxide nanoparticle injection but normalized by the study endpoint. Biodistribution analysis demonstrated that the nanoparticle coating dictated their accumulation across various organs, with significant tumor accumulation observed for pegylated iron oxide nanoparticles and Venofer®.ConclusionIron oxide nanoparticle formulations exert a transient effect on the host immune system and some exhibit tumor accumulation, suggesting their potential for further development in cancer imaging and treatment.

BELIEVE IT OR NOT

What’s wrong with this picture..?

Sep’2020

go2em

 

Jun’2020

go2em

 

Jan’21

go2em

Dec’2020

go2em

 

Nov’2020

go2em

 

Nov’2020

Georgia on my mind: What do Tbilisi and Atlanta have in common..? Well: Georgia!

go2em

 

Wanted

Send us a link to what you think Ripley would endorse 🙂 or comment one of the above

Write Us